Prostate cancer starts when cells in the prostate gland grow out of control. Those cells can spread to other parts of the body and affect healthy tissue. This can happen for several reasons. When ...

What Is the Gleason Grading System? Many people with prostates have cancer cells in their prostate that never grow into a tumor or spread. If your pathologist finds cancer cells in your biopsy ...

Grade Groups are a way for doctors to explain how close prostate cancer cells are in appearance to cells without cancer. Prostate cancer grading shows how quickly these cells may grow or spread ...

It's a given that every man should be concerned with their prostate health, due to the fact that only men have this ...

If you’re experiencing any signs of prostate cancer, don’t hesitate to reach out to your healthcare provider. Awareness and ...

Maintaining prostate health is vital for overall wellbeing in men. As men age, they become increasingly prone to prostate-related issues. Prostate supplements are designed to promote prostate ...

Oct. 17, 2024 — Researchers developed an approach to treating prostate cancer, successfully eliminating cancerous cells in 73% of patients in the ... An Early Blood Test Can Predict Survival in ...

A new treatment for non-cancerous enlargement of the prostate, a very common condition in older men, has been recommended for use by the NHS. It's called prostate artery embolisation. And it ...

Charities and doctors have welcomed the King going public about needing treatment for an enlarged prostate. It could encourage men with similar symptoms to get a check-up, they say. An enlarged ...

Sir Chris Hoy, six-time Olympic cycling champion, has revealed he has advanced prostate cancer. The 48-year-old said the cancer has spread to his bones and is terminal. Tributes have poured in and ...

NOBODY WANTS TO find out they have prostate cancer. Yet the earlier it's detected, the better. The cancer is very treatable when it's discovered early; you’ll have the most treatment options ...

CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13. Cell Reports Medicine , 2024; 101758 DOI: 10.1016/j.xcrm.2024.101758 ...